Long-term outcomes of immediate versus delayed nephroureterectomy for upper tract urothelial carcinoma

Journal of Endourology

Volumn 26, Issue 5, 2012, Pages 566-573

  Gadzinski, Adam J ^a   Roberts, William W ^a   Faerber, Gary J ^a   Wolf, J Stuart ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLEEDING; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METASTASIS; METASTASIS FREE SURVIVAL; NEPHRON SPARING SURGERY; NEPHROURETERECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; THERAPY DELAY; TRANSITIONAL CELL CARCINOMA; TREATMENT FAILURE; TUMOR VOLUME;

EID: 84860487277     PISSN: 08927790     EISSN: 1557900X     Source Type: Journal    
DOI: 10.1089/end.2011.0220     Document Type: Article

References (24)

1. Flanigan R. Urothelial tumors of the upper urinary tract. In: Wein A, Kavoussi L, Novick A, Partin A, Peters C, eds. Campbell-Walsh Urology. 9th ed. Philadelphia, PA: Elsevier Saunders, 2007, pp 1638-1652.
2. Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 2009;115:1224-1233.
3. Huffman JL, Bagley DH, Lyon ES, et al. Endoscopic diagnosis and treatment of upper-Tract urothelial tumors. A preliminary report. Cancer 1985;55:1422-1428.
4. Streem SB, Pontes EJ. Percutaneous management of upper tract transitional cell carcinoma. J Urol 1986;135: 773-775.
5. Krambeck AE, Thompson RH, Lohse CM, et al. Imperative indications for conservative management of upper tract transitional cell carcinoma. J Urol 2007;178:792-797.
6. Deligne E, Colombel M, Badet L, et al. Conservative management of upper urinary tract tumors. Eur Urol 2002;42: 43-48.
7. Gadzinski AJ, Roberts WW, Faerber GJ, Wolf JS Jr. Longterm outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma. J Urol 2010;183:2148-2153.
8. Lucas SM, Svatek RS, Olgin G, et al. Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery. BJU Int 2008;102:172-176.
9. Roupret M, Hupertan V, Traxer O, et al. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology 2006;67:1181-1187.
10. Sowter SJ, Ilie CP, Efthimiou I, Tolley DA. Endourologic management of patients with upper-Tract transitional-cell carcinoma: Long-Term follow-up in a single center. J Endourol 2007;21:1005-1009.
11. Thompson RH, Krambeck AE, Lohse CM, et al. Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. Urology 2008;71: 713-717.
12. Suh RS, Faerber GJ, Wolf JS Jr. Predictive factors for applicability and success with endoscopic treatment of upper tract urothelial carcinoma. J Urol 2003;170:2209-2216.
13. Wolf JS Jr, Dash A, Hollenbeck BK, et al. Intermediate followup of hand assisted laparoscopic nephroureterectomy for urothelial carcinoma: Factors associated with outcomes. J Urol 2005;173:1102-1107.
14. Keeley FX, Kulp DA, Bibbo M, et al. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol 1997;157:33-37.
15. Williams SK, Denton KJ, Minervini A, et al. Correlation of upper-Tract cytology, retrograde pyelography, ureteroscopic appearance, and ureteroscopic biopsy with histologic examination of upper-Tract transitional cell carcinoma. J Endourol 2008;22:71-76.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373-383.
17. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213.
18. Boorjian S, Ng C, Munver R, et al. Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma. Urology 2005;66:283-287.
19. Sundi D, Svatek RS, Margulis V, et al. Upper tract urothelial carcinoma: Impact of time to surgery. Urol Oncol Sep 23 2010. E-pub ahead of print.
20. Waldert M, Karakiewicz PI, Raman JD, et al. A delay in radical nephroureterectomy can lead to upstaging. BJU Int 2009;105:812-817.
21. Lee CT, Madii R, Daignault S, et al. Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. J Urol 2006;175:1262-1267.
22. Sánchez-Ortiz RF, Huang WC, Mick R, et al. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol 2003;169: 110-115.
23. Weizer AZ, Faerber GJ, Wolf JS Jr. Progression of disease despite good endoscopic local control of upper tract urothelial carcinoma. Urology 2007;70:469-472.
24. Jeldres C, Sun M, Isbarn H, et al. A population-based assessment of perioperative mortality after nephroureterectomy for upper-Tract urothelial carcinoma. Urology 2010;75: 315-320.